July 15, 2021: Richard Platt to Lead New IMPACT Collaboratory NIH Collaboratory Trial

Dr. Xioajuan Li and Dr. Richard Platt
Dr. Xioajuan Li and Dr. Richard Platt

Longtime NIH Collaboratory investigator Dr. Richard Platt will serve as co–principal investigator of a new embedded pragmatic clinical trial with Dr. Xiaojuan Li as part of the IMPACT Collaboratory. The IMPACT Collaboratory announced Li and Platt as awardees of its NIH Collaboratory Trials Program for their project Co-CARE-AD, the Collaborative Care Coordination Program for Alzheimer’s Disease and Related Dementias.

The IMPACT Collaboratory’s NIH Collaboratory Trials Program is a new funding mechanism to support full-scale, embedded pragmatic clinical trials testing nonpharmacologic interventions for people living with Alzheimer disease and related dementias and their care partners that are linked to the needs of a health care system.

Co-CARE-AD will evaluate the effectiveness of the Dementia Care Consultation program to provide multicomponent care coordination and support for community-dwelling Medicare Advantage plan members. Read more about Co-CARE-AD.

The NIA IMPACT Collaboratory is supported by a grant from the National Institute on Aging.